Global /South Korea /Healthcare /Drug Manufacturers - General /060590
chevron_leftBack
CTCBIO Inc. logo

CTCBIO Inc.

060590
KRX: 060590 Delayed
3,910KRW 1.3%
2.56 USD
As of 13 June 2026, CTCBIO Inc. has a market cap of $61.47M USD, ranking #29062 globally and #1579 in South Korea. It ranks #2631 in the Healthcare sector, and #935 in the Drug Manufacturers - General industry.
Global Rank
29062
Country Rank
1579
Sector Rank
2631
Industry Rank
935
Key Stats
Market Cap
$61.47MUSD
93.48B KRW
Enterprise Value
$77.86MUSD
118.83B KRW
Revenue (TTM)
$81.38MUSD
123.77B KRW
EBITDA (TTM)
$8.37MUSD
12.78B KRW
Net Income (TTM)
$2.13MUSD
3.24B KRW
EBITDA Margin
10%
Profit Margin
2.6%
PE Ratio
28.5
PS Ratio
0.8
PB Ratio
1.2
EV/EBITDA
9.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mingoo Lee open_in_new
Employees
248
Founded
1993
Website
ctcbio.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.3% 0.8% -0.9% -13% -28% -43%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
060590
(주)씨티씨바이오
ISIN: KR7060590007
Shares Out.:
23.909M1 Shares Float: 13.514M2
TV:
SA:
YF:
GF:
BA:
MS:
3,910 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About CTCBIO Inc.

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.15B
13.91T KRW
15K%
-
$6.77B
10.3T KRW
11K%
1958.1
$5.24B
7.97T KRW
8K%
29.9
298380
$4.96B
7.55T KRW
8K%
-
000100
$4.55B
6.92T KRW
7K%
35.9
$4.44B
6.76T KRW
7K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
1M%
38.1
JNJ
$547.28B
890K%
26.4
ABBV
$360.63B
587K%
97.4
$321.52B
256.25B CHF
523K%
19.9
AZN
$288.84B
215.59B GBP
470K%
27.6
NOVN
$274.65B
218.9B CHF
447K%
20.5
chevron_leftBack